Presents a comprehensive, systematic assessment of available scientific evidence for effects on health, social welfare or disability. Full assessments include economic, social and ethical impact analyses. Assessment teams include professional practitioners and academics. Before publication the report is reviewed by external experts, and scientific conclusions approved by the SBU Board of Directors.
How Patients Experience Chronic Pain
- The research on treating chronic pain unequivocally demonstrates a strong negative correlation between pain and quality of life, ie, pain reduction improves quality of life (Evidence Grade 1).
- Living with chronic pain requires a new orientation in life and the opportunity to talk about the experience (Evidence Grade 2).
- Patients with chronic pain are eager to retain their sense of dignity (Evidence Grade 1).
- The long-term impact of broad-based, coordinated rehabilitation programs, referred to as multimodal rehabilitation (usually a combination of psychological interventions and physical activity, physical exercise or physical therapy) is that pain decreases more, a greater number of people return to work and sick leaves are shorter than with passive control and/or limited, separate interventions (Evidence Grade 1). Because the studies on which that conclusion is based were structured in various different ways, any attempt to compare the magnitude of the effects may be misleading.
- Multimodal rehabilitation improves long-term functional ability in fibromyalgia patients more effectively than passive control or limited, separate interventions (Evidence Grade 2).
Cognitive behavioral Therapy
- Cognitive behavioral therapy yields better social and physical function, as well as 25% greater ability to cope, in chronic pain patients than other behavioral therapies, medications and physical therapy that have been studied and to no treatment at all (Evidence Grade 2).
- Paracetamol (acetaminophen) somewhat (effect size 0.21)* alleviates the pain of mild to moderate osteoarthritis (Evidence Grade 1). Paracetamol is more effective in combination with tramadol or another weak opioid than as monotherapy (Evidence Grade 1).
- COX-2 inhibitors and other nonsteroidal anti-inflammatory drugs (NSAIDs) reduce the pain of osteoarthritis and arthritis by at least 30% (Evidence Grade 1). Combining them with tramadol or another weak opioid can increase their effectiveness (Evidence Grade 1). All COX-2 inhibitors and other NSAIDs increase the risk of cardiovascular events (Evidence Grade 1). There is insufficient scientific evidence to draw any conclusions concerning possible differences between various classes of drugs.
- COX-2 inhibitors can be a cost-effective option for chronic pain patients with a high risk of gastrointestinal bleeding (Evidence Grade 2).
- Amitriptyline reduces the pain of peripheral and central neuropathic pain due to shingles (herpes zoster), diabetes and stroke patients by more than 20% (Evidence Grade 2).
- Tricyclic antidepressants moderately (effect size 0.52–0.56) alleviate fibromyalgia pain (Evidence Grade 2).
* Effect size: <0.20: insignificant; 0.20–0.50: small; 0.50–0.80: moderate; >0.80: large. Source: Treatment of Alcohol and Drug Abuse, SBU Report 156/2, 2001, pp 403-5.
- Strong opioids - number needed to treat (NNT)** approximately 2.6 – alleviate neuropathic pain in diabetes and shingles patients (Evidence Grade 1). Strong opioids reduce severe osteoarthritis pain by approximately 24% (Evidence Grade 1). Weak opioids reduce mild to moderate osteoarthritis and low back pain by approximately 40% (Evidence Grade 1). They are just as effective as NSAIDs for osteoarthritis pain (Evidence Grade 1). Both weak and strong opioids cause unpleasant adverse effects (the most common of which are constipation, fatigue, dizziness, nausea and vomiting) in more than half of all patients (Evidence Grade 1).
- Carbamazepine is effective (NNT 1.4–2.8) in trigeminal neuralgia (tic douloureux) (Evidence Grade 2). Gabapentin (Neurontin) reduces neuropathic pain (NNT 3.8 for at least 50%) in diabetes (Evidence Grade 2) and in patients with postherpetic (NNT 3.2) pain (Evidence Grade 1).
- Tramadol is more effective than placebo for nociceptive pain – approximately 20% of tramadol patients, as opposed to 40% of placebo patients, stop taking their medication due to insufficient relief (Evidence Grade 1). Tramadol alleviates neuropathic pain (NNT 4.3 for at least 50% pain relief) (Evidence Grade 3). Tramadol is as effective as weak opioids for musculoskeletal pain (Evidence Grade 1). Tramadol causes adverse affects to the same extent as weak and strong opioids (Evidence Grade 1).
- Capsaicin reduces (NNT 8 for at least 50%) neuropathic pain and osteoarthritis pain in small joint pain (Evidence Grade 1).
- The research results are contradictory when it comes to the effectiveness of glucosamine in relieving osteoarthritis pain.
** Number of patients who must be treated before one of them is likely to benefit. The lower, the better.
- Spinal cord stimulation reduces the frequency of angina attacks by 50% and improves quality of life, both short-term and long-term, in patients with severe angina pectoris or the ischemic symptoms of peripheral arterial disease (Evidence Grade 1).
- Radiofrequency denervation (Evidence Grade 3) can provide short-term relief of chronic neck and back (including whiplashrelated) pain but poses a risk of serious complications. Physical Activity, Physical Exercise, Relaxation, biofeedback, Massage, Manipulation, Physical Therapy and Orthosis
- Active, specific and professionally supervised exercise alleviates chronic pain 20-30% more effectively than treatment that does not involve physical activity (Evidence Grade 1).
- Treatment strategies that include physical activity are more cost-effective in alleviating chronic low back pain than standard primary care, that does not involve specific measures (Evidence Grade 3).
- Western acupuncture alleviates chronic low back pain more effectively than placebo (Evidence Grade 1).
- There is strong scientific evidence that acupuncture alleviates low back pain, lateral epicondylitis (tennis elbow), neck and shoulder pain as effectively as other treatments (Evidence Grade 1).
- Balneotherapy (mud or mineral baths) reduces chronic musculoskeletal pain by 20–30% (Evidence Grade 3).
- In orofacial pain, occlusal splints and behavioral therapies such as biofeedback and cognitive behavioral therapy give better pain relief than no therapy at all (Evidence Grade 3).
Chronic Pain in Children
- Psychological methods (NNT 2.35) alleviate tension (muscle contraction) headaches in children more effectively than placebo, standard primary care (which does not involve specific measures) or no treatment at all (Evidence Grade 1).
How to cite this report:
SBU. Methods of treating chronic pain. Stockholm: Swedish Council on Health Technology Assessment in Health Care (SBU); 2006. SBU report no 177/1 (in Swedish).
SBU. Methods of treating chronic pain. Stockholm: Swedish Council on Health Technology Assessment in Health Care (SBU); 2006. SBU report no 177/2 (in Swedish).
More on the subject
Haggman-Henrikson B, Alstergren P, Davidson T, Hogestatt ED, Ostlund P, Tranaeus S, et al. Pharmacological treatment of oro-facial pain - health technology assessment including a systematic review with network meta-analysis. J Oral Rehabil 2017;44:800-26.